Pappas Capital Portfolio Company VelosBio to be Acquired by Merck
- Thursday, November 5, 2020, 7:00
- Finance
- Add a comment
RESEARCH TRIANGLE PARK, N.C., Nov. 5, 2020 /PRNewswire/ — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the “Company”), has entered into a definitive agreement to be acquired by…
About the Author
adminasapcorp has written 39134 stories on this site.